Is medical management useful in Moyamoya disease?

Table 1 The antithrombotic treatment for Moyamoya disease

Antithrombotic treatment	Rationale
Single antiplatelet regimen [agents: ASA (50-325 mg) per day; clopidogrel (75 mg) per day; cilostazol (200 mg) per day]	Primary stroke prevention in embolic detection by TCD; Secondary stroke prevention
Dual antiplatelet regimen	No role
Anticoagulant	Contra-indicated
Thrombolysis	Use with caution

ASA: Acetylsalicylic acid; TCD: Transcranial doppler.